Real-time broad-range PCR versus blood culture. A prospective pilot study in pediatric cancer patients with fever and neutropenia
- 1 March 2007
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 15 (6) , 637-641
- https://doi.org/10.1007/s00520-007-0235-x
Abstract
In a pilot study, results of real-time broad-range (16S rRNA) polymerase chain reaction (PCR) performed on 45 blood samples of pediatric cancer patients with fever and neutropenia were compared with blood culture results. The PCR assay used, having proven a high sensitivity in artificially spiked blood samples, was positive in only three of ten blood culture-positive samples, and it was positive in 10 of 35 (29%) culture-negative samples. This broad-range PCR assay, which may identify not-grown bacteria potentially contributing to fever, needs improvement in sensitivity, and different reasons for positive PCR in negative blood culture samples need to be assessed before clinical application.Keywords
This publication has 6 references indexed in Scilit:
- Real-Time Quantitative Broad-Range PCR Assay for Detection of the 16S rRNA Gene Followed by Sequencing for Species IdentificationJournal of Clinical Microbiology, 2006
- New developments in the diagnosis of bloodstream infectionsThe Lancet Infectious Diseases, 2004
- Use of Quantitative 16S Ribosomal DNA Detection for Diagnosis of Central Vascular Catheter-Associated Bacterial InfectionJournal of Clinical Microbiology, 2004
- Etiologic Diagnosis of Infective Endocarditis by Broad-Range Polymerase Chain Reaction: A 3-Year ExperienceClinical Infectious Diseases, 2003
- Does Blood of Healthy Subjects Contain Bacterial Ribosomal DNA?Journal of Clinical Microbiology, 2001
- Detection of bacteraemia in patients with fever and neutropenia using 16S rRNA gene amplification by polymerase chain reactionEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998